Women with PCOS show an increase in the bioactivity of IGF-1, resulting from an increase in IGF-1 levels in non-obese patients or from a reduction in insulin-like growth factor-binding protein-1 (IGFBP-1) concentrations in obese patients. The gene discussed is IGFBP1; the disease is polycystic ovary syndrome.